Table 5 Absolute value and change of parameters for each group at each moment.

From: The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients

  

At baseline

Change at interval

At Boolean remission

Change at interval

After Boolean remission

p-value

SDAI

G ≤ 6

13.3 (12.9)

− 11.0 (12.7)***

1.03 (1.04)

1.88 (2.40)***

2.91 (2.40)

0.68, 0.49, ***

G > 6

13.3 (9.8)

− 11.5 (9.7)***

1.10 (1.00)

2.96 (2.98)***

4.05 (3.03)

HAQ-DI

G ≤ 6

0.418 (0.564)

− 0.045 (0.246)***

0.370 (0.551)

− 0.006 (0.232)***

0.364 (0.510)

**, ***, ***

G > 6

0.578 (0.607)

− 0.029 (0.315)***

0.552 (0.600)

0.015 (0.254)

0.567 (0.599)

PS-VAS

G ≤ 6

30.3 (28.9)

− 17.0 (28.0)***

13.0 (18.4)

4.7 (15.7)***

17.7 (14.9)

***, ***, ***

G > 6

40.5 (29.6)

− 19.9 (31.9)***

20.7 (24.5)

3.4 (19.0)***

24.1 (17.7)

SHS

G ≤ 6

28.3 (51.3)

0.0 (0.5)***

27.3 (49.8)

− 0.2 (1.5)***

26.5 (48.6)

***, ***, ***

G > 6

69.1 (78.9)

− 0.4 (7.5)

70.7 (79.4)

− 0.2 (1.7)*

69.0 (77.8)

QOLS

G ≤ 6

0.847 (0.131)

0.073 (0.134)***

0.845 (0.139)

− 0.017 (0.075)***

0.828 (0.108)

***, 0.79, ***

G > 6

0.805 (0.113)

0.018 (0.130)***

0.791 (0.139)

− 0.026 (0.084)

0.765 (0.128)

  1. Standard deviations in parentheses are shown.
  2. In change at interval rows, *, **, and *** represented statistical significance of p < 0.05, p < 0.01, and p < 0.001 respectively, for which were evaluated time to time change using ANOVA with repeated measures.
  3. In p-value rows, *, **, and *** represented statistical significance of p < 0.05, p < 0.01, and p < 0.001 respectively, for which were evaluated differences between G ≤ 6 and G > 6 group for each moment at baseline, Boolean remission, and after Boolean remission, respectively.
  4. SDAI simplified disease activity index, HAQ-DI Health Assessment Questionnaire Disability Index, PS-VAS pain score with visual analog scale, SHS Sharp/van der Heijde score, QOLS quality of life score.